maxwellt/fedgrantsembedded huggingface dataset:
DoD Autism, Idea Development Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-15
Estimated total program funding: 2640000
Expected number of awards: 4
Cost sharing or matching requirement: No

The FY24 ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for Autistic individuals. Applications are strongly encouraged to address one of the FY24 ARP Idea Development Award Areas of Interest or provide justification that the proposed research addresses a critical problem, question, or need in ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.Research funded by the FY24 ARP should be responsive to the needs of people with ASD, their families, and/or caregivers. Researchers are therefore encouraged to establish and utilize effective collaborations and partnerships with community members to maximize the translational and impact potential of the proposed research.CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women’s health outcomes and/or advancing knowledge for women’s health.
DoD Autism, Career Development Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-15
Estimated total program funding: 2640000
Expected number of awards: 4
Cost sharing or matching requirement: No

The FY24 ARP Career Development Award supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct innovative, high-impact ideas or early-phase, proof-of-principle clinical trials with the potential to have a major impact on ASD. Applications are strongly encouraged to address one of the FY24 ARP Career Development Award Areas of Interest or provide justification that the proposed research addresses a critical problem, question, or need in ASD.This award enables such investigators to compete for funding separately from investigators with established programs of ASD research. Previous experience in ASD research is allowed, but not required. However, in FY24 Career Development Award applications that name a Principal Investigator (PI) with limited background in ASD research, the ARP strongly encourages the inclusion of collaboration with investigators who are experienced in ASD research and/or possess other relevant expertise in order to strengthen the application. PIs must meet specific eligibility criteria as described in Section II.C, Eligibility Information.Research funded by the FY24 ARP should be responsive to the needs of people with ASD, their families, and/or caregivers. Researchers are therefore encouraged to establish and utilize effective collaborations and partnerships with community members to maximize the translational and impact potential of the proposed research.CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women’s health outcomes and/or advancing knowledge for women’s health.
DoD Spinal Cord Injury Research Program Investigator-Initiated Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-30
Estimated total program funding: 6720000
Expected number of awards: 8
Cost sharing or matching requirement: No

The SCIRP IIRA is intended to support studies that have the potential to make an important contribution to SCI research, patient care, and/or quality of life.Important aspects of this award mechanism include:• Impact: Applications should articulate the short- and long-term impact of the proposed research on both the SCI research field as well as the SCI community. Projects must address one or more of the FY24 SCIRP Focus Areas.• Relevance to Military Health: Projects should be relevant to spinal cord-injured military Service Members, Veterans, and/or their Family members and care partners. Collaboration with military and VA researchers and clinicians is encouraged.• Preliminary Data: Observations that drive a research idea may be derived from laboratory discovery, population-based studies, a clinician’s first-hand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to the mission of the SCIRP and support the proposed research project.IIRA applications may focus on any phase of research from basic through translational, though studies focused exclusively on target identification are discouraged. Permitted research includes preclinical studies in animal models (except where otherwise specified), research with human subjects or human anatomical substances, as well as ancillary studies associated with an existing clinical trial.
DoD Autism, Clinical Trial Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-15
Estimated total program funding: 6560000
Expected number of awards: 2
Cost sharing or matching requirement: No

The ARP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ASD. Applications are strongly encouraged to address one of the FY24 ARP Clinical Trial Award Areas of Interest. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.Research funded by the FY24 ARP should be responsive to the needs of people with ASD, their families, and/or caregivers. Researchers are therefore encouraged to establish and utilize effective collaborations and partnerships with community members to maximize the impact potential of the proposed research.CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women’s health outcomes and/or advancing knowledge for women’s health.
DOD Spinal Cord Injury Research Program Translational Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-30
Estimated total program funding: 10320000
Expected number of awards: 5
Cost sharing or matching requirement: No

The SCIRP TRA is intended to support translational research that will accelerate the movement of promising ideas in SCI research into clinical applications. Although not all-inclusive, some examples include demonstration studies of pharmaceuticals and medical devices in preclinical systems and/or clinical research on therapeutics, devices, or practice using human tissues or resources.The ultimate goal of translational research is to move an observation forward into clinical application and accelerate the clinical introduction of health care products, technologies, or practice guidelines. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinician’s first-hand knowledge of patients and anecdotal data. However, applicants should not view translational research as a one-way continuum from bench to bedside. The research plan is encouraged to involve a reciprocal flow of ideas and information between basic and clinical science.
DoD Hearing Restoration Focused Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-09
Estimated total program funding: 4400000
Expected number of awards: 4
Cost sharing or matching requirement: No

The FY24 HRRP FRA mechanism is intended to support promising research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system injury. Applicants are encouraged to leverage resources and expertise at the National Center for Advancing Translational Sciences (NCATS) to improve efficiency and accelerate the translational process. A list of NCATS programs and resources supporting preclinical innovation can be found at https://ncats.nih.gov/preclinical. Applications from investigators within the military Services and applications involving multidisciplinary collaborations among academia, industry, the military Services, the VA, and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.
Supporting American-Style Higher Education in Iraq 2024
Agency: Assistance Coordination
Posted: 2024-03-26 | Closing date: 2024-05-19
Estimated total program funding: 10000000
Award ceiling: 3000000
Award floor: 1000000
Expected number of awards: 4
Cost sharing or matching requirement: No

The Bureau of Near Eastern Affairs, Office of Assistance Coordination (NEA/AC), seeks applications to support and strengthen American-style IHEs in Iraq.Please see the link to my grants for submission instructions: https://mygrants.servicenowservices.com/mygrants?id=mygrants_form&table=x_g_usd4_d_grant_funding_opportunity&sys_id=e50facef8785865005fb7777cebb35ce&view=Default

Eligibility: Eligible applicants must be an American-style Institution of Higher Education in Iraq, to include the Iraqi Kurdistan Region, that is non-state sponsored and offers a postsecondary level academic curriculum that leads to a vocational, associate’s, bachelor’s, or higher degree.
Spinal Cord Injury Research Program Clinical Trial Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-30
Estimated total program funding: 14560000
Expected number of awards: 3
Cost sharing or matching requirement: No

The SCIRP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of SCI. Applications should articulate both the short- and long-term impact of the proposed research on individuals with SCI and/or their care partners. The proposed intervention(s) to be tested should offer significant potential impact for individuals affected by SCI within the context of one or more of the FY24 SCIRP Focus Areas.
Spinal Cord Injury Research Program Clinical Translation Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-30
Estimated total program funding: 4160000
Expected number of awards: 2
Cost sharing or matching requirement: No

The SCIRP CTRA is intended to support high-impact and/or new/emerging clinical research that may not be ready for a larger-scale clinical trial and for which feasibility/pilot/optimization studies are necessary. Projects should demonstrate potential to impact the standard of care, both immediate and long term, or contribute to evidence-based guidelines for the evaluation and care of military Service Members, Veterans, and other individuals living with SCI.
Ovarian Cancer Research Program Investigator-Initiated Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-08-06
Estimated total program funding: 15360000
Expected number of awards: 9
Cost sharing or matching requirement: No

The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature.
DoD Ovarian Cancer Research Program Ovarian Cancer Academy - Leadership Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-08-06
Estimated total program funding: 2800000
Expected number of awards: 1
Cost sharing or matching requirement: No

The OCRP seeks to advance ovarian cancer research through development of early-career investigators. The OCRP Ovarian Cancer Academy (OCA) is a unique, interactive environment providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty to move ovarian cancer research into a new frontier. The overarching goal of the OCA is to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment to enhance quality and expand quantity of the ovarian cancer research field.
Ovarian Cancer Clinical Trial Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-08-06
Estimated total program funding: 6400000
Expected number of awards: 2
Cost sharing or matching requirement: No

The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.
DoD Ovarian Cancer Clinical Trial Translational Endpoints Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-08-06
Estimated total program funding: 1600000
Expected number of awards: 1
Cost sharing or matching requirement: No

The FY24 OCRP Clinical Trial Translational Endpoints Research Award intends to support correlation of clinical trial-related data (e.g., biosample analysis, imaging, or epidemiological data) with clinical outcomes or responses to therapies. Correlative studies may be associated with a past, ongoing, or future clinical trial in order to associate various factors (genetic, DOD FY24 Ovarian Cancer Clinical Trial Translational Endpoints Research Award 4biochemical, environmental and others) with initiation, progression, metastasis, recurrence, prognosis, diagnosis or effect of intervention on ovarian cancer outcomes. The translational research should address high-impact or unmet needs in ovarian cancer. The proposed research may be hypothesis testing or may be designed to generate new hypotheses to be tested in follow-up clinical research. The award may not be used to directly support a clinical trial.
DoD Ovarian Cancer Research Program Pilot Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-08-06
Estimated total program funding: 4800000
Expected number of awards: 10
Cost sharing or matching requirement: No

The OCRP Pilot Award supports the exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. The proposed research must demonstrate a clear focus on ovarian cancer (e.g., using tissues, cell lines, datasets, or appropriate animal models), and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s).
DoD Peer Reviewed Medical, Investigator-Initiated Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-05-23
Estimated total program funding: 30000000
Expected number of awards: 20
Cost sharing or matching requirement: No

The PRMRP Investigator-Initiated Research Award (IIRA) supports fundamental research studies that will make an important contribution toward research, patient care, and/or quality of life for a disease or condition related to one of the FY24 PRMRP Topic Areas and one of the FY24 PRMRP Strategic Goals. This award mechanism is intended to support basic research that is exploratory in nature and seeks to further or validate preliminary findings for short- or long-term impact. Research projects may focus on any stage of basic laboratory research, ranging from fundamental research for the generation of knowledge, hypothesis, or models, to expansion of mature data.The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinician’s first-hand knowledge of patients, or anecdotal data. The project should include a well-formulated testable hypothesis based on existing evidence. Applications must include relevant preliminary data that support the rationale and feasibility for the proposed study. These data may be unpublished or from the published literature.This award mechanism is not intended to support translational research. Applicants seeking funding for projects that have progressed beyond the realm of basic research should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.
DoD Vision Research, Mentored Clinical Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-08-23
Estimated total program funding: 225000
Expected number of awards: 3
Cost sharing or matching requirement: No

The FY24 VRP MCRA is intended to support patient-oriented vision injury research and develop research expertise of highly motivated military or civilian clinicians in training. Research supported by the MCRA can be a standalone study of high impact to vision injury care or the generation of clinical research data in preparation for a more expansive study.Each MCRA must be led by an established clinician or Ph.D. clinical scientist who will serve as Principal Investigator (PI) of the award. Key personnel must include a clinician in training (e.g., a fellow, resident, junior clinician, clinician in a Ph.D. program). The clinician in training should have sufficient time remaining in their training program to complete the research proposed under the MCRA. The clinician in training will conduct the proposed research under the mentorship of the PI, with support from supporting personnel as appropriate. While additional junior scientists or clinicians may participate in the research, only one clinician in training may be designated as mentee. A Letter of Organizational Support and Mentee Eligibility, signed by the Department Chair or appropriate organization official, and a Letter of Commitment, signed by the mentee, should be submitted as part of Attachment 2: Supporting Documentation.For the purposes of this award mechanism, clinical research is defined as research conducted with human subjects or research on material of human origin, such as tissues or specimens or data obtained from human subjects. Documentation of Institutional Review Board (IRB)/ Ethics Committee (EC) approval or exemption by December 1, 2024, is required for an MCRA application to be considered for funding. See Attachment 2: Supporting Documentation for additional detail.The MCRA may not be used to conduct preclinical research (including animal research) or clinical trials.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Studies that retrospectively analyze data generated from previously conducted clinical trial(s) are not considered a clinical trial.
DoD Peer Reviewed Medical, Clinical Trial Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-08-19
Estimated total program funding: 90000000
Expected number of awards: 12
Cost sharing or matching requirement: No

The FY24 PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the congressionally directed FY24 PRMRP Topic Areas and FY24 PRMRP Strategic Goals. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale phase 1 to phase 3 trials to determine efficacy in relevant patient populations.Applications from investigators within the military Services and applications involving multidisciplinary collaborations among academia, industry, the military Services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women's health outcomes and/or advancing knowledge for women's health.Funding from this award mechanism must support a clinical trial. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.
DoD Peer Reviewed Medical, Technology/Therapeutic Development Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-06-06
Estimated total program funding: 90000000
Expected number of awards: 15
Cost sharing or matching requirement: No

The PRMRP Technology/Therapeutic Development Award (TTDA) is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY24 PRMRP Topic Areas and one of the FY24 PRMRP Strategic Goals. Products in development should be responsive to the health care needs of military Service Members, Veterans, and their Families. The product(s) to be developed under the PRMRP TTDA mechanism may be a tangible item, such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product. (A “knowledge product” is a non-materiel product that addresses an identified need in a topic area, is based on current evidence and research, aims to transition into medical practice, training, tools, or to support materiel solutions [systems to develop, acquire, provide, and sustain medical solutions and capabilities], and educates or impacts behavior throughout the continuum of care, including primary prevention of negative outcomes.)The Technology/Therapeutic Development Award is not intended for basic research. Applicants generating preliminary data, basic research, performing high-risk/high-gain studies should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.
Building a Community of Practice for Women in Strategic Trade (WiST)
Agency: Bureau of International Security-Nonproliferation
Posted: 2024-03-26 | Closing date: 2024-05-28
Award ceiling: 641225
Award floor: 443925
Expected number of awards: 1
Cost sharing or matching requirement: No

To implement a project aimed at advancing U.S. foreign policy and national security priorities by supporting initiatives that make decision-making structures and processes in fragile, conflict, or crisis-affected contexts more reflective of and responsive to the needs and perspectives of partner states to ensure strategic trade control systems meet international standards and by engaging on bilateral, regional and multilateral levels with foreign governments to aid in the establishment of independent capabilities to regulate transfers of weapons of mass destruction, WMD-related items, conventional arms, and related dual-use items, and to detect, interdict, investigate, and prosecute illicit transfers of such items.

Eligibility: Domestic Non-federal entities (including state, local government, Indian tribe, institutions of higher education (IHE), or nonprofit organization), Foreign Non-Profit Organizations, Domestic & Foreign For-Profit Organizations (must waive fee/profit), and Foreign Public Entities (including Foreign Public International Organizations).
Nonproliferation
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2024-03-26 | Closing date: 2027-01-15
Award ceiling: 350000
Cost sharing or matching requirement: No

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Strategic Trade Facilitation in Southeast Asia: Promoting U.S.-Philippines and U.S.-Vietnam Technology Partnerships
Agency: Bureau of International Security-Nonproliferation
Posted: 2024-03-26 | Closing date: 2024-05-28
Award ceiling: 1602372
Award floor: 1602372
Expected number of awards: 10
Cost sharing or matching requirement: No

To implement a project aimed at advancing U.S. foreign policy and national security priorities outlined in the Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 (Div. A, P.L. 117-167). The Act established a new International Technology Security and Innovation Fund (ITSI Fund) to “to support the development and adoption of secure semiconductors, [and] semiconductor supply chains” with the goal to make the global semiconductor supply chain more resilient, diversified, and secure.

Eligibility: Domestic Non-federal entities (including state, local government, Indian tribe, institutions of higher education (IHE), or nonprofit organization), Foreign Non-Profit Organizations, Domestic & Foreign For-Profit Organizations (must waive fee/profit), and Foreign Public Entities (including Foreign Public International Organizations).
Nonproliferation
DoD Peer Reviewed Medical, Discovery Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-05-23
Estimated total program funding: 20600000
Expected number of awards: 50
Cost sharing or matching requirement: No

The PRMRP Discovery Award is intended to support innovative, untested, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. The proposed project may be exploratory, hypothesis-driven, or hypothesis-generating research but must be novel and must be based on a strong scientific rationale and a well-developed study design and plan of analysis. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation or product development. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for groundbreaking future research projects.This award is not intended to support/validate ongoing research and inclusion of preliminary data is not allowed. Inclusion of preliminary data other than serendipitous finding is not consistent with the exploratory nature of this award. Applicants seeking funding for research to further an existing research project should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.
CIG- FY 2024 - Missouri
Agency: Natural Resources Conservation Service
Posted: 2024-03-26 | Closing date: 2024-05-27
Applications must be received by 11:59 pm Eastern Time.
Estimated total program funding: 500000
Award ceiling: 250000
Award floor: 50000
Expected number of awards: 3
Cost sharing or matching requirement: No

Notice of Funding Opportunity Summary NRCS is announcing the availability of Conservation Innovation Grants (CIG) State Program funding to stimulate the development and adoption of innovative conservation approaches and technologies. Applications are accepted from eligible entities (Section C) for projects carried out in the state of Missouri. A total of up to $500,000.00 is available for the Missouri CIG competition in FY 2024. All non-Foreign, non-federal entities (NFE) and individuals are invited to apply, with the sole exception of federal agencies. Projects may be between one and three years in duration. The maximum award amount for a single award in FY 2024 is $250,000.00. For new users of Grants.gov, see Section D. of the full Notice of Funding Opportunity for information about steps required before submitting an application via Grants.gov. Completing all steps required to start an application can take a significant amount of time, plan accordingly. Key Dates Applicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on May 25th, 2024. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or support@grants.gov. Awarding agency staff cannot support applicants regarding Grants.gov accounts. For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility, or the merits of a specific proposal will not be addressed. A webinar for CIG applicants is scheduled for April 8, 2024 at 9 a.m. CT Standard Time. Information on how to participate in the webinar will be posted to the Missouri NRCS CIG website along with a link below. Applicants are encouraged to visit the MO State CIG website to learn more about the CIG program. Link to webinar Teams meeting: https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZWE5MTdiYWQtYjM3Yi00ZmVjLThhNzMtZjdjNzBlZjQ5ZTNi%40thread.v2/0?context=%7b%22Tid%22%3a%22ed5b36e7-01ee-4ebc-867e-e03cfa0d4697%22%2c%22Oid%22%3a%22cd47cf8d-9f96-4309-87f4-c21c3a497296%22%7d The agency anticipates making selections by July 1st and expects to execute awards by September 30th. These dates are estimates and are subject to change.
DoD Peer Reviewed Medical, Lifestyle and Behavioral Health Interventions Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-06-06
Estimated total program funding: 27000000
Expected number of awards: 6
Cost sharing or matching requirement: No

The FY24 PRMRP Lifestyle and Behavioral Health Interventions Research Award (LBIRA) supports clinical research and/or clinical trials using a combination of scientific disciplines including behavioral health, psychology, psychometrics, biostatistics and epidemiology, surveillance, and public health. Applications are required to address and provide a solution to one of the congressionally directed FY24 PRMRP Topic Areas and FY24 PRMRP Strategic Goals.The overall intent of the FY24 PRMRP LBIRA mechanism is to promote evidence-based and patient-centered approaches to improve health and/or disease-related outcomes and enhance the patient experience in defined populations. Research ideas may include, but are not limited to:• Development and testing for efficacy of lifestyle interventions and symptom management approaches to minimize disease risk and maximize quality of life.• Studies to investigate the impact of prevention, diagnostics, treatment, or health care delivery approaches on health outcomes.• Studies to assess the relationship(s) between behavioral, cognitive, and/or social functioning in relation to disease or condition initiation, progression, detection, treatment, and rehabilitation.• Studies to examine and improve quality of life or decision-making.• Population-focused studies to identify behavioral and lifestyle predictors of disease and/or disease progression.
DoD Peer Reviewed Medical, Impact Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-26 | Closing date: 2024-06-06
Estimated total program funding: 47400000
Expected number of awards: 14
Cost sharing or matching requirement: No

The FY24 PRMRP Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applicability. The intent of the Impact Award is to translate the fundamental understanding of underlying mechanisms toward practical applications that have the potential for major near-term impact on patients affected by one of the diseases and conditions included in the FY24 PRMRP Topic Areas.Proposed research should refine mature concepts and ideas into translatable solutions with a view toward evaluating technical feasibility of promising new pharmacological agents, knowledge products, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and/or emerging approaches and technologies. The FY24 PRMRP Impact Award is not intended to support basic research.For the purposes of this funding opportunity, basic research is defined as exploratory science directed toward greater knowledge or understanding of the fundamental aspects of phenomena or outcomes, without specific applications toward process and products. Examples include, but are not limited to, high-risk/high-gain approaches, mechanistic studies, and preliminary data generation/validation. Applicants seeking funding for research that meets this definition should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.
OVW Fiscal Year 2024 Special Tribal Criminal Jurisdiction (STCJ) Grant Program
Agency: Office on Violence Against Women
Posted: 2024-03-26 | Closing date: 2024-07-09
Award ceiling: 0
Award floor: 0
Expected number of awards: 10
Cost sharing or matching requirement: No

The OVW Special Tribal Criminal Jurisdiction Grant Program (Tribal Jurisdiction Program) (Assistance Listing # 16.025) supports tribes in their efforts to exercise special Tribal criminal jurisdiction (STCJ) over non-Indians who commit "covered crimes" within the Tribe's jurisdictional boundaries and provides technical assistance for planning and implementing changes in their criminal justice systems necessary to exercise the jurisdiction. "Covered crimes" are: assault of Tribal justice personnel; child violence; dating violence; domestic violence; obstruction of justice; sexual violence; sex trafficking; stalking; and violation of a protection order. The program supports tribes in preparing to exercise or exercising the jurisdiction to ensure that victims find safety and justice and that non-Indians who commit covered crimes within their communities are held accountable.

Eligibility: Eligible applicants are limited to: Governments of Indian tribes that have jurisdiction over Indian Country.
FY 2024 National Environmental Information Exchange Network Grant Program
Agency: Environmental Protection Agency
Posted: 2024-03-27 | Closing date: 2024-05-23
Estimated total program funding: 10500000
Award ceiling: 500000
Expected number of awards: 35
Cost sharing or matching requirement: No

The EPA Exchange Network Grant Program is soliciting project applications to support the Environmental Information Exchange Network (EN) to:Facilitate sharing of environmental data, especially through shared and reusable services.Reduce burden and avoid costs for co-regulators and the regulated community.Streamline data collection and exchanges to improve its timeliness for decision making.Increase the quality and access to environmental data through discovery, publishing, outbound and analytical services so it is more useful to environmental managers.Increase data and IT management capabilities needed to fully participate in the EN. 

Eligibility: See Section III of the Notice of Funding Opportunity for eligibility information.
Tribal Self-Governance Planning Cooperative Agreement Program
Agency: Indian Health Service
Posted: 2024-03-27 | Closing date: 2024-06-12
Estimated total program funding: 720000
Award ceiling: 180000
Award floor: 180000
Expected number of awards: 3
Cost sharing or matching requirement: No

The purpose of this Planning Cooperative Agreement is to provide resources to Tribes interested in entering the Tribal Self-Governance Program (TSGP) and to existing Self Governance Tribes interested in assuming new or expanded PSFAs. Title V of the Indian Self-Determination and Education Assistance Act (ISDEAA) requires a Tribe or Tribal organization (T/TO) to complete a planning phase to the satisfaction of the Tribe. The planning phase must include legal and budgetary research and internal Tribal government planning and organizational preparation relating to the administration of health care programs.The planning phase is critical to negotiations and helps Tribes make informed decisions about which Programs, Services, Functions, and Activities (PSFAs to assume and what organizational changes or modifications are necessary to successfully support those PSFAs. A thorough planning phase improves timeliness and efficient negotiations and ensures that the Tribe is fully prepared to assume the transfer of IHS PSFAs to the Tribal health program.A Planning Cooperative Agreement is not a prerequisite to enter the TSGP and a Tribe may use other resources to meet the planning requirement. Tribes that receive Planning Cooperative Agreements are not obligated to participate in the TSGP and may choose to delay or decline participation based on the outcome of their planning activities. This also applies to existing Self Governance Tribes exploring the option to expand their current PSFAs or assume additional PSFAs.

Eligibility: To be eligible for this opportunity, applicant must meet the following criteria:    • Applicant must be an “Indian Tribe” as defined in 25 U.S.C. 5304(e); a “Tribal Organization” as defined in 25 U.S.C. 5304(l); or an “Inter Tribal Consortium” as defined at 42 CFR 137.10. Please note that Tribes prohibited from contracting pursuant to the ISDEAA are not eligible. See section 424(a) of the Consolidated Appropriations Act, 2014, Public Law No. 113 76, as amended by section 445 of the Consolidated Appropriations Act, 2023, Public Law No. 117 328, and the Continuing Appropriations Act, 2024 and Other Extensions Act, Public Law   No. 118-15.     • Pursuant to 25 U.S.C. 5383(c)(1)(B), applicant must request participation in self governance by resolution or other official action by the governing body of each Indian Tribe to be served. Note:  If the applicant has already successfully completed the planning phase required and requested participation in the IHS Tribal Self Governance Program by official Tribal action, then the applicant is not eligible for this funding opportunity.     • Pursuant to 25 U.S.C. 5383(c)(1)(C), applicant must demonstrate financial stability and financial management capability for 3 fiscal years.
BJA FY24 Competitive DNA Capacity Enhancement for Backlog Reduction (CEBR) Program
Agency: Bureau of Justice Assistance
Posted: 2024-03-27 | Closing date: 2024-05-22
Award ceiling: 1000000
Award floor: 0
Expected number of awards: 10
Cost sharing or matching requirement: No

OJP is committed to advancing work that promotes civil rights and racial equity, increases access to justice, supports crime victims and individuals impacted by the justice system, strengthens community safety and protects the public from crime and evolving threats, and builds trust between law enforcement and the community. With this solicitation, BJA seeks to provides funding to states and units of local government with existing crime laboratories that conduct DNA analysis to solve crimes and protect public safety by maximizing the effective utilization of DNA technology to process DNA samples for entry into the Combined DNA Index System (CODIS).
BJA FY24 Formula DNA Capacity Enhancement for Backlog Reduction (CEBR) Program
Agency: Bureau of Justice Assistance
Posted: 2024-03-27 | Closing date: 2024-05-22
Award ceiling: 3500000
Award floor: 0
Expected number of awards: 130
Cost sharing or matching requirement: No

With this solicitation, BJA seeks applications for funding under the FY 2024 Formula DNA Capacity Enhancement for Backlog Reduction (CEBR) Program. This program funds states and units of local government with existing crime laboratories that conduct DNA analysis to process, and/or to increase the capacity to process, more DNA samples for entry into the Combined DNA Index System (CODIS) by publicly funded forensic DNA and DNA database laboratories, thereby helping to reduce the number of forensic DNA and DNA database samples awaiting analysis and/or to prevent a backlog of forensic and database DNA samples.
Tribal Self-Governance Planning Cooperative Agreement Program
Agency: Indian Health Service
Posted: 2024-03-27 | Closing date: 2024-06-12
No Explanation
Estimated total program funding: 720000
Award ceiling: 180000
Award floor: 180000
Expected number of awards: 3
Cost sharing or matching requirement: No

The purpose of this Planning Cooperative Agreement is to provide resources to Tribes interested in entering the Tribal Self-Governance Program (TSGP) and to existing Self Governance Tribes interested in assuming new or expanded PSFAs. Title V of the Indian Self-Determination and Education Assistance Act (ISDEAA) requires a Tribe or Tribal organization (T/TO) to complete a planning phase to the satisfaction of the Tribe. The planning phase must include legal and budgetary research and internal Tribal government planning and organizational preparation relating to the administration of health care programs. The planning phase is critical to negotiations and helps Tribes make informed decisions about which Programs, Services, Functions, and Activities (PSFAs to assume and what organizational changes or modifications are necessary to successfully support those PSFAs. A thorough planning phase improves timeliness and efficient negotiations and ensures that the Tribe is fully prepared to assume the transfer of IHS PSFAs to the Tribal health program. A Planning Cooperative Agreement is not a prerequisite to enter the TSGP and a Tribe may use other resources to meet the planning requirement. Tribes that receive Planning Cooperative Agreements are not obligated to participate in the TSGP and may choose to delay or decline participation based on the outcome of their planning activities. This also applies to existing Self Governance Tribes exploring the option to expand their current PSFAs or assume additional PSFAs.

Eligibility: To be eligible for this opportunity, applicant must meet the following criteria:  • Applicant must be an “Indian Tribe” as defined in 25 U.S.C. 5304(e); a “Tribal Organization” as defined in 25 U.S.C. 5304(l); or an “Inter Tribal Consortium” as defined at 42 CFR 137.10. Please note that Tribes prohibited from contracting pursuant to the ISDEAA are not eligible. See section 424(a) of the Consolidated Appropriations Act, 2014, Public Law No. 113 76, as amended by section 445 of the Consolidated Appropriations Act, 2023, Public Law No. 117 328, and the Continuing Appropriations Act, 2024 and Other Extensions Act, Public Law  No. 118-15.   • Pursuant to 25 U.S.C. 5383(c)(1)(B), applicant must request participation in self governance by resolution or other official action by the governing body of each Indian Tribe to be served. Note:  If the applicant has already successfully completed the planning phase required and requested participation in the IHS Tribal Self Governance Program by official Tribal action, then the applicant is not eligible for this funding opportunity.   • Pursuant to 25 U.S.C. 5383(c)(1)(C), applicant must demonstrate financial stability and financial management capability for 3 fiscal years.